InvestorsHub Logo
Followers 63
Posts 24430
Boards Moderated 0
Alias Born 11/23/2016

Re: None

Thursday, 04/19/2018 4:01:11 PM

Thursday, April 19, 2018 4:01:11 PM

Post# of 5918
Share price not taking off probably because the market view the DEA hurdle as the real issue with FDA approval baked into the current price level.

I have no means of foretelling the DEA decision, but if retained as a class 1 drug in the first round it will simply take another or two rounds more with pressure building. Especially with EMA marketing approval in hand.